Effekte einer vaginalen Applikation von ultra-niedrig dosiertem Estriol (Gynoflor®) auf die Sexualität bei Brustkrebspatientinnen mit atropher Vaginitis unter Aromatasehemmer Therapie
M Mögele(University Hospital Regensburg), Stefanie Buchholz(University Hospital Schleswig-Holstein), P. Neven(Universitair Ziekenhuis Leuven), Olaf Ortmann(University of Regensburg), Anneleen Lintermans(Universitair Ziekenhuis Leuven), Gert Bellen(Flemish Community), Gilbert Donders(Institut Scientifique de Santé Publique), P. J. Grob, V. Prasauskas
Cited by 0
Related Papers
Survival and safety of exemestane versus tamoxifen after 2–3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial
|The Lancet|2007|912
Predictive value for preterm birth of abnormal vaginal flora, bacterial vaginosis and aerobic vaginitis during the first trimester of pregnancy
|BJOG An International Journal of Obstetrics & Gynaecology|2009|436
Aerobic vaginitis: no longer a stranger
|Research in Microbiology|2017|242
Aerobic vaginitis in pregnancy
|BJOG An International Journal of Obstetrics & Gynaecology|2011|186
Prediction of recurrence after treatment for high‐grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation
|BJOG An International Journal of Obstetrics & Gynaecology|2006|139